Mark Sundahl
Psychiatry · Kansas City, MONPI 1194189555
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 199 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,852 and has fallen 84.8% since, to $281 in 2022.
Across 199 payments — averaging $14.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$461
- AbbVie$405
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$315
- Vanda Pharmaceuticals Inc.$238
- Lundbeck LLC$229
- Neurocrine Biosciences, Inc.$187
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,902100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 24 | $461 |
| AbbVie(2 entities) | 23 | $405 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $315 |
| Vanda Pharmaceuticals Inc. | 10 | $238 |
| Lundbeck LLC | 17 | $229 |
| Neurocrine Biosciences, Inc. | 12 | $187 |
| Eisai Inc. | 9 | $140 |
| Avanir Pharmaceuticals, Inc. | 5 | $99 |
| Biogen | 5 | $94 |
| Neos Therapeutics, LP | 6 | $93 |
| Tris Pharma Inc | 4 | $77 |
| Bausch Health US, LLC | 5 | $73 |
| Teva Pharmaceuticals USA, Inc. | 6 | $71 |
| Jazz Pharmaceuticals Inc. | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $62 |
| Merck | 4 | $58 |
| Adlon Therapeutics L.p. | 4 | $55 |
| Sunovion Pharmaceuticals Inc. | 17 | $45 |
| Ironshore Pharmaceuticals Inc. | 3 | $43 |
| Alkermes, Inc. | 2 | $42 |
| Acadia Pharmaceuticals Inc | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $12 |
| Almatica Pharma LLC | 1 | $11 |
How this compares
$2,902 in reported general payments places this provider in the 80th percentile of 680 psychiatry providers in Missouri.
Other psychiatry in Kansas City
- Brian BarashKansas City$856K
- Mark CannonKansas City$19K
- Syed KarimKansas City$17K
- Asim UlusaracKansas City$12K
- Christine TruebloodKansas City$12K
- Kevin KennettKansas City$12K
- Gregory MattingleySaint Charles$4.7M
- Vadim BaramSaint Louis$1.9M
- Adam SkySaint Louis$1.1M
- Mohd MalikSaint Louis$956K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.